Skip to main content

Table 4 Predictive value of BNP at cut-off values for a demand of second line therapy

From: Rediscover the predictive capacity of B-type natriuretic peptide applied to neonatal supraventricular tachycardia

Treatment

BNP > 2460.5pg/ml

BNP ≤ 2460.5pg/ml

X2

P

First line therapy (n, %)

10 (62.5%)

25 (92.6%)

5.89

0.04

Second line therapy (n, %)

6 (37.5%)

2 (7.4%)

  1. Vagal maneuver, adenosine, esmolol and digitalis are defined as first line therapy; DC cardioversion, propafenone, and amiodarone are defined as second line therapy; BNP: B-type natriuretic peptide
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us